// App-Quantinova.ai

4320 : Predictive value of VTE-BLEED to predict major bleeding and other adverse events in a practice-based cohort of patients with venous thromboembolism: results of the XALIA study

Researchers

Presenter

  • F A Klok

Principal Investigators

  • S Barco

  • A G G Turpie

  • S Haas

  • R Kreutz

  • L G Mantovani

  • M Gebel

  • D Monje

  • J B Brugge

  • M Bach

Medical Centers

  • Leiden University Medical Centre, Leiden, Netherlands

  • Ctr for Thrombosis and Hemostasis, Mainz, Germany

  • McMaster University, Internal Medicine, Hamilton, Canada

  • Technical University Munich, 3rd Department of Medicine, Munich, Germany

  • Charite Univsmedizin Berlin, Berlin, Germany

  • University of Milan, Milan, Italy

  • Bayer Pharma AG, Berlin, Germany

  • Bayer Vital GmbH, Leverkusen, Germany

  • Darmstadt Clinic, Darmstadt, Germany

Locations

  • Netherlands

  • Germany

  • Canada

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Non Interventional

  • Multinational

  • Multicenteric

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved